A
Aileron Therapeutics Inc
NASDAQ:RNTX
Aileron Therapeutics Inc
NASDAQ:RNTX
Price:
1.27
USD
-2.31%
Market Closed
Market Cap:
$33.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aileron Therapeutics Inc
NASDAQ:RNTX
|
US |
|
Henan Pinggao Electric Co Ltd
SSE:600312
|
CN |
|
Cathay Real Estate Development Co Ltd
TWSE:2501
|
TW |
Balance Sheet
Balance Sheet Decomposition
Aileron Therapeutics Inc
Aileron Therapeutics Inc
Balance Sheet Decomposition is not available for
Aileron Therapeutics Inc
Aileron Therapeutics Inc
Balance Sheet
Aileron Therapeutics Inc
Aileron Therapeutics Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
6
|
4
|
21
|
12
|
11
|
5
|
7
|
4
|
5
|
17
|
|
| Cash Equivalents |
6
|
4
|
21
|
12
|
11
|
5
|
7
|
4
|
5
|
17
|
|
| Short-Term Investments |
10
|
0
|
0
|
39
|
10
|
13
|
7
|
42
|
16
|
0
|
|
| Other Current Assets |
1
|
0
|
0
|
1
|
1
|
1
|
3
|
2
|
1
|
1
|
|
| Total Current Assets |
17
|
4
|
21
|
52
|
22
|
20
|
16
|
48
|
22
|
18
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
7
|
6
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
7
|
6
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
79
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Other Long-Term Assets |
0
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Total Assets |
18
N/A
|
6
-66%
|
22
+271%
|
53
+139%
|
30
-42%
|
26
-13%
|
16
-38%
|
48
+197%
|
22
-55%
|
106
+382%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
2
|
2
|
1
|
2
|
1
|
2
|
1
|
|
| Accrued Liabilities |
1
|
2
|
2
|
3
|
4
|
4
|
2
|
3
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
4
|
5
|
5
|
6
|
4
|
5
|
3
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+19%
|
4
+58%
|
5
+20%
|
11
+119%
|
10
-3%
|
4
-60%
|
5
+10%
|
3
-26%
|
8
+128%
|
|
| Equity | |||||||||||
| Common Stock |
98
|
98
|
130
|
0
|
0
|
0
|
0
|
0
|
0
|
92
|
|
| Retained Earnings |
83
|
96
|
114
|
137
|
168
|
198
|
219
|
245
|
273
|
289
|
|
| Additional Paid In Capital |
1
|
2
|
3
|
185
|
188
|
214
|
231
|
289
|
291
|
295
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
16
N/A
|
3
-78%
|
18
+434%
|
48
+166%
|
20
-59%
|
16
-18%
|
12
-24%
|
44
+261%
|
19
-58%
|
98
+428%
|
|
| Total Liabilities & Equity |
18
N/A
|
6
-66%
|
22
+271%
|
53
+139%
|
30
-42%
|
26
-13%
|
16
-38%
|
48
+197%
|
22
-55%
|
106
+382%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
5
|
5
|
5
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
